SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-011408
Filing Date
2015-01-15
Accepted
2015-01-15 08:42:36
Documents
5
Period of Report
2015-01-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d851944d8k.htm 8-K 18580
2 EXHIBIT 4.4 d851944dex44.htm EX-4.4 71561
3 EXHIBIT 10.43 d851944dex1043.htm EX-10.43 70170
4 EXHIBIT 99.1 d851944dex991.htm EX-99.1 8980
5 GRAPHIC g851944g88s54.jpg GRAPHIC 10256
  Complete submission text file 0001193125-15-011408.txt   184962
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 15528462
SIC: 2834 Pharmaceutical Preparations